Immune-mediated inflammatory disease patients' preferences in adverse drug reaction information regarding biologics
SourceExpert Opinion on Drug Safety, 19, 8, (2020), pp. 1049-1054
Article / Letter to editor
Display more detailsDisplay less details
Expert Opinion on Drug Safety
SubjectAll institutes and research themes of the Radboud University Medical Center; Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health Sciences; Radboudumc 5: Inflammatory diseases RIMLS: Radboud Institute for Molecular Life Sciences
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.